213 related articles for article (PubMed ID: 16298997)
21. Loop202-208 in avian sarcoma virus integrase mediates tetramer assembly and processing activity.
Bosserman MA; O'Quinn DF; Wong I
Biochemistry; 2007 Oct; 46(40):11231-9. PubMed ID: 17845008
[TBL] [Abstract][Full Text] [Related]
22. Rous sarcoma virus integrase protein: mapping functions for catalysis and substrate binding.
Bushman FD; Wang B
J Virol; 1994 Apr; 68(4):2215-23. PubMed ID: 8139006
[TBL] [Abstract][Full Text] [Related]
23. Changes in the mechanism of DNA integration in vitro induced by base substitutions in the HIV-1 U5 and U3 terminal sequences.
Brin E; Leis J
J Biol Chem; 2002 Mar; 277(13):10938-48. PubMed ID: 11788585
[TBL] [Abstract][Full Text] [Related]
24. Comparison of enzymatic activities of the HIV-1 and HFV integrases to their U5 LTR substrates.
Oh YT; Shin CG
Biochem Mol Biol Int; 1999 Apr; 47(4):621-9. PubMed ID: 10319414
[TBL] [Abstract][Full Text] [Related]
25. Subcellular localization of avian sarcoma virus and human immunodeficiency virus type 1 integrases.
Kukolj G; Jones KS; Skalka AM
J Virol; 1997 Jan; 71(1):843-7. PubMed ID: 8985428
[TBL] [Abstract][Full Text] [Related]
26. Human immunodeficiency virus, type 1 protease substrate specificity is limited by interactions between substrate amino acids bound in adjacent enzyme subsites.
Ridky TW; Cameron CE; Cameron J; Leis J; Copeland T; Wlodawer A; Weber IT; Harrison RW
J Biol Chem; 1996 Mar; 271(9):4709-17. PubMed ID: 8617736
[TBL] [Abstract][Full Text] [Related]
27. Multimerization determinants reside in both the catalytic core and C terminus of avian sarcoma virus integrase.
Andrake MD; Skalka AM
J Biol Chem; 1995 Dec; 270(49):29299-306. PubMed ID: 7493962
[TBL] [Abstract][Full Text] [Related]
28. High-resolution structure of the catalytic domain of avian sarcoma virus integrase.
Bujacz G; Jaskólski M; Alexandratos J; Wlodawer A; Merkel G; Katz RA; Skalka AM
J Mol Biol; 1995 Oct; 253(2):333-46. PubMed ID: 7563093
[TBL] [Abstract][Full Text] [Related]
29. Analysis of conserved and non-conserved amino acids critical for ALSV (Avian leukemia and sarcoma viruses) integrase functions in vitro.
Moreau K; Faure C; Verdier G; Ronfort C
Arch Virol; 2002 Sep; 147(9):1761-78. PubMed ID: 12209315
[TBL] [Abstract][Full Text] [Related]
30. Identification of HIV-1 integrase inhibitors via three-dimensional database searching using ASV and HIV-1 integrases as targets.
Chen IJ; Neamati N; Nicklaus MC; Orr A; Anderson L; Barchi JJ; Kelley JA; Pommier Y; MacKerell AD
Bioorg Med Chem; 2000 Oct; 8(10):2385-98. PubMed ID: 11058033
[TBL] [Abstract][Full Text] [Related]
31. Activities and substrate specificity of the evolutionarily conserved central domain of retroviral integrase.
Kulkosky J; Katz RA; Merkel G; Skalka AM
Virology; 1995 Jan; 206(1):448-56. PubMed ID: 7831800
[TBL] [Abstract][Full Text] [Related]
32. Characterization of a naphthalene derivative inhibitor of retroviral integrases.
Daniel R; Myers CB; Kulkosky J; Taganov K; Greger JG; Merkel G; Weber IT; Harrison RW; Skalka AM
AIDS Res Hum Retroviruses; 2004 Feb; 20(2):135-44. PubMed ID: 15018700
[TBL] [Abstract][Full Text] [Related]
33. Structure of the catalytic domain of avian sarcoma virus integrase with a bound HIV-1 integrase-targeted inhibitor.
Lubkowski J; Yang F; Alexandratos J; Wlodawer A; Zhao H; Burke TR; Neamati N; Pommier Y; Merkel G; Skalka AM
Proc Natl Acad Sci U S A; 1998 Apr; 95(9):4831-6. PubMed ID: 9560188
[TBL] [Abstract][Full Text] [Related]
34. Changes to the HIV long terminal repeat and to HIV integrase differentially impact HIV integrase assembly, activity, and the binding of strand transfer inhibitors.
Dicker IB; Samanta HK; Li Z; Hong Y; Tian Y; Banville J; Remillard RR; Walker MA; Langley DR; Krystal M
J Biol Chem; 2007 Oct; 282(43):31186-96. PubMed ID: 17715137
[TBL] [Abstract][Full Text] [Related]
35. An amino acid in the central catalytic domain of three retroviral integrases that affects target site selection in nonviral DNA.
Harper AL; Sudol M; Katzman M
J Virol; 2003 Mar; 77(6):3838-45. PubMed ID: 12610159
[TBL] [Abstract][Full Text] [Related]
36. The use of a new in vitro reaction substrate reproducing both U3 and U5 regions of the HIV-1 3'-ends increases the correlation between the in vitro and in vivo effects of the HIV-1 integrase inhibitors.
Tramontano E; Onidi L; Esposito F; Badas R; La Colla P
Biochem Pharmacol; 2004 May; 67(9):1751-61. PubMed ID: 15081874
[TBL] [Abstract][Full Text] [Related]
37. Characterization of the nuclear localization signal in the avian sarcoma virus integrase.
Kukolj G; Katz RA; Skalka AM
Gene; 1998 Nov; 223(1-2):157-63. PubMed ID: 9858717
[TBL] [Abstract][Full Text] [Related]
38. A mutation in integrase can compensate for mutations in the simian immunodeficiency virus att site.
Du Z; Ilyinskii PO; Lally K; Desrosiers RC; Engelman A
J Virol; 1997 Nov; 71(11):8124-32. PubMed ID: 9343162
[TBL] [Abstract][Full Text] [Related]
39. Expression and characterization of the integrase of bovine immunodeficiency virus.
Avidan O; Hizi A
Virology; 2008 Feb; 371(2):309-21. PubMed ID: 17976681
[TBL] [Abstract][Full Text] [Related]
40. Mutations in the U5 sequences adjacent to the primer binding site do not affect tRNA cleavage by rous sarcoma virus RNase H but do cause aberrant integrations in vivo.
Oh J; Chang KW; Hughes SH
J Virol; 2006 Jan; 80(1):451-9. PubMed ID: 16352569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
